Morse Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.81M | Buy |
17,535
+2,210
| +14% | +$490K | 0.79% | 37 |
|
|
2025
Q4 | $3.5M | Buy |
15,325
+2,057
| +16% | +$469K | 0.7% | 44 |
|
|
2025
Q3 | $3.07M | Buy |
13,268
+6,270
| +90% | +$1.28M | 0.61% | 47 |
|
|
2025
Q2 | $1.3M | Sell |
6,998
-150
| -2% | -$27.9K | 0.28% | 78 |
|
|
2025
Q1 | $1.5M | Sell |
7,148
-165
| -2% | -$32.1K | 0.38% | 63 |
|
|
2024
Q4 | $1.3M | Sell |
7,313
-250
| -3% | -$46K | 0.3% | 74 |
|
|
2024
Q3 | $1.49M | Buy |
7,563
+175
| +2% | +$32.7K | 0.32% | 72 |
|
|
2024
Q2 | $1.27M | Sell |
7,388
-500
| -6% | -$82.8K | 0.31% | 72 |
|
|
2024
Q1 | $1.44M | Sell |
7,888
-2
| -0% | -$345 | 0.37% | 66 |
|
|
2023
Q4 | $1.22M | Sell |
7,890
-1,010
| -11% | -$147K | 0.36% | 67 |
|
|
2023
Q3 | $1.33M | Sell |
8,900
-13,806
| -61% | -$2.03M | 0.42% | 64 |
|
|
2023
Q2 | $3.06M | Sell |
22,706
-34,353
| -60% | -$5.04M | 0.93% | 38 |
|
|
2023
Q1 | $9.09M | Sell |
57,059
-1,280
| -2% | -$196K | 3.07% | 4 |
|
|
2022
Q4 | $9.43M | Sell |
58,339
-437
| -0.7% | -$67K | 3.42% | 3 |
|
|
2022
Q3 | $7.89M | Sell |
58,776
-240
| -0.4% | -$34.4K | 2.98% | 6 |
|
|
2022
Q2 | $9.04M | Buy |
59,016
+2,190
| +4% | +$335K | 2.9% | 7 |
|
|
2022
Q1 | $9.21M | Sell |
56,826
-2,625
| -4% | -$381K | 2.29% | 7 |
|
|
2021
Q4 | $8.05M | Buy |
59,451
+625
| +1% | +$73.8K | 1.8% | 14 |
|
|
2021
Q3 | $6.35M | Sell |
58,826
-2,473
| -4% | -$283K | 1.51% | 16 |
|
|
2021
Q2 | $6.91M | Sell |
61,299
-1,270
| -2% | -$143K | 1.67% | 14 |
|
|
2021
Q1 | $6.77M | Buy |
62,569
+5,085
| +9% | +$544K | 1.74% | 15 |
|
|
2020
Q4 | $6.16M | Buy |
57,484
+6,645
| +13% | +$639K | 1.71% | 15 |
|
|
2020
Q3 | $4.45M | Sell |
50,839
-420
| -0.8% | -$39.5K | 1.43% | 18 |
|
|
2020
Q2 | $5.03M | Buy |
51,259
+8,454
| +20% | +$744K | 1.79% | 17 |
|
|
2020
Q1 | $3.26M | Buy |
42,805
+4,000
| +10% | +$341K | 1.56% | 18 |
|
|
2019
Q4 | $3.44M | Buy |
38,805
+27,055
| +230% | +$2.25M | 1.18% | 25 |
|
|
2019
Q3 | $890K | Hold |
11,750
| – | – | 0.33% | 70 |
|
|
2019
Q2 | $854K | Sell |
11,750
-200
| -2% | -$15.7K | 0.25% | 83 |
|
|
2019
Q1 | $963K | Sell |
11,950
-15,535
| -57% | -$1.27M | 0.29% | 73 |
|
|
2018
Q4 | $2.53M | Sell |
27,485
-2,680
| -9% | -$236K | 0.9% | 35 |
|
|
2018
Q3 | $2.85M | Sell |
30,165
-19,795
| -40% | -$1.88M | 0.75% | 43 |
|
|
2018
Q2 | $4.63M | Sell |
49,960
-13,200
| -21% | -$1.29M | 1.27% | 24 |
|
|
2018
Q1 | $5.98M | Buy |
63,160
+615
| +1% | +$67.6K | 1.66% | 15 |
|
|
2017
Q4 | $6.05M | Buy |
62,545
+1,035
| +2% | +$97.5K | 1.68% | 17 |
|
|
2017
Q3 | $5.47M | Buy |
61,510
+8,120
| +15% | +$618K | 1.63% | 16 |
|
|
2017
Q2 | $3.87M | Buy |
53,390
+14,785
| +38% | +$994K | 1.26% | 26 |
|
|
2017
Q1 | $2.52M | Buy |
+38,605
| New | +$2.43M | 0.86% | 40 |
|
Other funds holding ABBV
VCM
VPM
Morse Asset Management's ABBV Position: Q1 2026 in Review
Morse Asset Management increased its AbbVie (ABBV) stake by 14% in Q1 2026, buying an estimated $490K and bringing the position to 17,535 shares worth $3.81M. The position accounts for 0.79% of the portfolio, ranked #37.
Morse Asset Management first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. The position peaked at $9.43M in Q4 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Morse Asset Management held 17,535 shares of AbbVie worth $3.81M as of Q1 2026.
- Morse Asset Management bought 2,210 AbbVie shares in Q1 2026, an estimated $490K.
- AbbVie made up 0.79% of Morse Asset Management's portfolio in Q1 2026, its #37 holding.
- Morse Asset Management first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
- Morse Asset Management's AbbVie position peaked at $9.43M in Q4 2022.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Morse Asset Management's 13F filing for Q1 2026, filed 14 May 2026.